
Journal of Medicinal Chemistry p. 3390 - 3395 (1991)
Update date:2022-08-02
Topics:
Lartey, Paul A.
DeNinno, Shari L.
Faghih, Ramin
Hardy, Dwight J.
Clement, Jacob J.
et al.
Selective protection of (9R)-9-amino-9-deoxoerythromycin A allowed for elimination of the 12-hydroxyl group to afford a versalite 12,21-olefin intermediate.Further modifications of the intermediate led to the syntheses of (9R)-9-deoxo-9-(N,N-dimethylamino
View MoreContact:+86-633-8332928
Address:No.1,Huanghai Yilu.Rizhao,Shandong
Beijing Apis Biotechnology Co., Ltd.
Contact:86-010-67856775-8551
Address:NO.4PUHUANGYU ROAD,FENTAI DISTRICT, BEIJING, CHINA
wuxi huabin bio-tech Co.,Ltd(expird)
Contact:86-0510-85133006
Address:hubin road NO157
Hangzhou Zhenghan Biological Technology Co., Ltd.
Contact:86-571-88781753
Address:liangzhu yuhang hangzhou city
Shijiazhuang Yunxuan Im&Export Co.,Ltd.
Contact:+86-311-83037514
Address:No.6 Hongbin Road
Doi:10.1016/j.bmcl.2012.03.071
(2012)Doi:10.1007/s11164-019-04072-z
(2020)Doi:10.1039/c2cc31439h
(2012)Doi:10.3109/14756366.2011.593515
(2012)Doi:10.1002/ejoc.201101604
(2012)Doi:10.1002/ejoc.201900177
(2019)